SCHEMBL1764167

SCHEMBL1764167

O=[PH](O)C(NC(c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 1/20 0.39
RAB9A P51151 1/20 0.39
GRM7 Q14831 1/20 0.39
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.38
ALOX15 P16050 1/20 0.38
HPGDS O60760 2/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 4/20 0.36
CYP2D6 P10635 1/20 0.35
SRC P12931 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15768409 0.84 IDO1 (0.40) MTORRAB9AGRM7TSHRCYP3A4
SCHEMBL1764563 0.78 TSHR (0.41) MTORRAB9AGRM7TSHRCYP3A4
SCHEMBL3874438 0.73 EPHX1 (0.41) MTORRAB9AGRM7ALDH1A1
SCHEMBL2487254 0.72 MTOR (0.43) MTORRAB9AGRM7TSHRCYP3A4
SCHEMBL3281034 0.72 MTOR (0.57) MTORRAB9AGRM7TSHRCYP3A4
SCHEMBL15275314 0.72 ACP3 (0.51) ALDH1A1LMNACYP2D6MAPK1KMT2A
SCHEMBL8858822 0.70 LMNA (0.44) TSHRALDH1A1LMNACYP2D6SRC
SCHEMBL9540931 0.70 LMNA (0.44) TSHRALDH1A1LMNACYP2D6SRC
SCHEMBL1764713 0.69 CES2 (0.42) ALDH1A1LMNACYP2D6SRCMAPK1
SCHEMBL1764710 0.69 CES2 (0.42) ALDH1A1LMNACYP2D6SRCMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10131681-B2 Aminophosphinic derivatives that can be used in the treatment of pain PHARMALEADS (FR) 2018-11-20 US disclosed
US-20140161839-A1 AMINOPHOSPHINIC DERIVATIVES THAT CAN BE USED IN THE TREATMENT OF PAIN PHARMALEADS (FR) 2014-06-12 US disclosed
US-8703747-B2 Aminophosphinic derivatives that can be used in the treatment of pain PHARMALEADS (FR) 2014-04-22 US disclosed
US-20110124601-A1 AMINOPHOSPHINIC DERIVATIVES THAT CAN BE USED IN THE TREATMENT OF PAIN PHARMALEADS 2011-05-26 US disclosed
US-6518260-B1 (α-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2003-02-11 US disclosed
US-6391866-B1 ANALGESICS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2002-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124601-A1 AMINOPHOSPHINIC DERIVATIVES THAT CAN BE USED IN THE TREATMENT OF PAIN OPRM1, HRH3, HRH4 MTOR 2537/4885RAB9A 1366/4885GRM7 93/4885
US-10131681-B2 Aminophosphinic derivatives that can be used in the treatment of pain OPRM1, HRH3, HRH4 MTOR 2584/4885RAB9A 1352/4885GRM7 95/4885
US-20140161839-A1 AMINOPHOSPHINIC DERIVATIVES THAT CAN BE USED IN THE TREATMENT OF PAIN OPRM1, HRH3, HRH4 MTOR 2584/4885RAB9A 1352/4885GRM7 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.